We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
(-6%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-17.18%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$17.1M |
| 2 |
MOMO
Hello Group
MOMO
|
+$5.31M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
+$4.25M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$4.13M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
+$94.3M |
| 2 |
Vipshop
VIPS
|
+$47.3M |
| 3 |
DigitalBridge
DBRG
|
+$39.3M |
| 4 |
Brookdale Senior Living
BKD
|
+$37.8M |
| 5 |
Criteo S.A. Ordinary Shares
CRTO
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Curis
CRIS
$9.71M
| $762K | 0.05% |
992
+489
| +97% | +$234K |
|
177
Teva Pharmaceuticals
TEVA
$40.4B
| $746K | 0.05% |
48,000
+5,000
| +12% | +$88.2K |
|
178
Citigroup
C
$213B
| $744K | 0.05% |
12,000
| – | – |
|
179
Procter & Gamble
PG
$340B
| $733K | 0.05% |
7,075
-8,125
| -53% | -$791K |
|
180
Amgen
AMGN
$209B
| $726K | 0.05% |
3,870
+540
| +16% | +$103K |
|
181
Abeona Therapeutics
ABEO
$355M
| $719K | 0.05% |
3,956
+1,080
| +38% | +$193K |
|
|
PVLA
182
Palvella Therapeutics
PVLA
$2.05B
| $710K | 0.05% |
2,784
+438
| +19% | +$104K |
|
183
Fortis
FTS
$29.3B
| $689K | 0.04% |
+10,330
| New | +$367K |
|
|
BOLD
184
DELISTED
Audentes Therapeutics, Inc
BOLD
| $687K | 0.04% |
18,427
-7,573
| -29% | -$217K |
|
185
Assembly Biosciences
ASMB
$498M
| $686K | 0.04% |
2,833
| – | – |
|
186
Algonquin Power & Utilities
AQN
$4.59B
| $670K | 0.04% |
+33,300
| New | +$364K |
|
187
Corvus Pharmaceuticals
CRVS
$1.1B
| $669K | 0.04% |
170,974
+11,992
| +8% | +$50.6K |
|
188
First Majestic Silver
AG
$7.52B
| $662K | 0.04% |
100,000
| – | – |
|
189
Infosys
INFY
$51B
| $652K | 0.04% |
59,930
| – | – |
|
|
ARQL
190
DELISTED
Arqule Inc
ARQL
| $642K | 0.04% |
+138,000
| New | +$533K |
|
191
Avnet
AVT
$6.86B
| $639K | 0.04% |
+15,000
| New | +$633K |
|
|
AGRX
192
DELISTED
Agile Therapeutics
AGRX
| $630K | 0.04% |
206
-27
| -12% | -$57.2K |
|
193
Cummins
CMI
$83.6B
| $624K | 0.04% |
4,000
| – | – |
|
194
Deckers Outdoor
DECK
$14.1B
| $613K | 0.04% |
25,020
| – | – |
|
195
Home Depot
HD
$337B
| $598K | 0.04% |
3,131
-6,159
| -66% | -$1.13M |
|
196
Johnson & Johnson
JNJ
$640B
| $592K | 0.04% |
4,265
-3,300
| -44% | -$442K |
|
|
FL
197
DELISTED
Foot Locker
FL
| $591K | 0.04% |
9,790
| – | – |
|
198
Viking Therapeutics
VKTX
$3.88B
| $589K | 0.04% |
69,203
| – | – |
|
|
AGN
199
DELISTED
Allergan plc
AGN
| $587K | 0.04% |
+4,000
| New | +$580K |
|
200
Protagonist Therapeutics
PTGX
$8.55B
| $585K | 0.04% |
47,513
-49,000
| -51% | -$433K |
|
Similar funds
NC
T2I
BA
IAA
THL
MHC
BWM
KHCM
Fosun International's Q1 2019 Portfolio in Review
As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Fosun International opened a new position in Baozun worth $20.3M.
- Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
- Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
- Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
- Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
- Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
- Fosun International opened 45 new positions and closed 37 in Q1 2019.
- Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.
Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.